SCLEROSOL (talc)
SCLEROSOL is indicated for the treatment of Tinea Pedis; Tinea Corporis.
Details
- Status
- Prescription
- First Approved
- 1997-12-24
- Routes
- INTRAPLEURAL
- Dosage Forms
- AEROSOL
SCLEROSOL Approval History
What SCLEROSOL Treats
2 indicationsSCLEROSOL is approved for 2 conditions since its original approval in 1997. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Tinea Pedis
- Tinea Corporis
SCLEROSOL Competitive Set
ProThree rings of competition based on shared molecular targets and treated indications.
Indication competitors
Same indication, different mechanism — what else might this patient receive?
Filters applied: drops same-active-ingredient (505(b)(2) reformulations), route-mismatch (topical vs systemic), and cross-therapeutic-area matches in same-indication rings.
Drugs Similar to SCLEROSOL
3 of 17FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Clinical Trial Registry
2 trials| Trial | Sponsor ID | Phase | Status | Title |
|---|---|---|---|---|
| NCT04792970 results posted | Pro00107258 | Ph 4 | terminated | Randomized Controlled Trial of Talc Instillation In Addition To Daily Drainage Through a Tunneled Pleural Catheter to Improve Rates of Outpatient Pleurodesis in Patients With Malignant Pleural Effusion |
| NCT02674243 | 03315 | Ph 3 | completed | Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion |
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
SCLEROSOL FDA Label Details
Indications & Usage
FDA Label (PDF)SCLEROSOL is indicated for the treatment of Tinea Pedis; Tinea Corporis.
Track SCLEROSOL with TheraRadar Pro
Watchlist alerts, full database access, CSV exports across 14,000+ drugs.
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.